S&P 500   3,836.44 (+0.19%)
DOW   31,113.64 (-0.92%)
QQQ   315.56 (+0.87%)
AAPL   123.01 (+1.67%)
MSFT   233.36 (+1.91%)
FB   262.43 (+3.04%)
GOOGL   2,029.08 (+0.65%)
AMZN   3,076.47 (+0.63%)
TSLA   676.97 (-0.77%)
NVDA   547.08 (+2.78%)
BABA   239.97 (-0.09%)
CGC   32.50 (-2.14%)
GE   12.64 (-0.94%)
MU   91.32 (+3.63%)
NIO   46.36 (-0.96%)
AMD   84.29 (+2.27%)
T   28.02 (-2.13%)
F   11.75 (-0.09%)
ACB   10.67 (-1.39%)
DIS   189.17 (-0.95%)
BA   212.07 (-2.02%)
NFLX   541.19 (-1.01%)
BAC   35.01 (-2.56%)
S&P 500   3,836.44 (+0.19%)
DOW   31,113.64 (-0.92%)
QQQ   315.56 (+0.87%)
AAPL   123.01 (+1.67%)
MSFT   233.36 (+1.91%)
FB   262.43 (+3.04%)
GOOGL   2,029.08 (+0.65%)
AMZN   3,076.47 (+0.63%)
TSLA   676.97 (-0.77%)
NVDA   547.08 (+2.78%)
BABA   239.97 (-0.09%)
CGC   32.50 (-2.14%)
GE   12.64 (-0.94%)
MU   91.32 (+3.63%)
NIO   46.36 (-0.96%)
AMD   84.29 (+2.27%)
T   28.02 (-2.13%)
F   11.75 (-0.09%)
ACB   10.67 (-1.39%)
DIS   189.17 (-0.95%)
BA   212.07 (-2.02%)
NFLX   541.19 (-1.01%)
BAC   35.01 (-2.56%)
S&P 500   3,836.44 (+0.19%)
DOW   31,113.64 (-0.92%)
QQQ   315.56 (+0.87%)
AAPL   123.01 (+1.67%)
MSFT   233.36 (+1.91%)
FB   262.43 (+3.04%)
GOOGL   2,029.08 (+0.65%)
AMZN   3,076.47 (+0.63%)
TSLA   676.97 (-0.77%)
NVDA   547.08 (+2.78%)
BABA   239.97 (-0.09%)
CGC   32.50 (-2.14%)
GE   12.64 (-0.94%)
MU   91.32 (+3.63%)
NIO   46.36 (-0.96%)
AMD   84.29 (+2.27%)
T   28.02 (-2.13%)
F   11.75 (-0.09%)
ACB   10.67 (-1.39%)
DIS   189.17 (-0.95%)
BA   212.07 (-2.02%)
NFLX   541.19 (-1.01%)
BAC   35.01 (-2.56%)
S&P 500   3,836.44 (+0.19%)
DOW   31,113.64 (-0.92%)
QQQ   315.56 (+0.87%)
AAPL   123.01 (+1.67%)
MSFT   233.36 (+1.91%)
FB   262.43 (+3.04%)
GOOGL   2,029.08 (+0.65%)
AMZN   3,076.47 (+0.63%)
TSLA   676.97 (-0.77%)
NVDA   547.08 (+2.78%)
BABA   239.97 (-0.09%)
CGC   32.50 (-2.14%)
GE   12.64 (-0.94%)
MU   91.32 (+3.63%)
NIO   46.36 (-0.96%)
AMD   84.29 (+2.27%)
T   28.02 (-2.13%)
F   11.75 (-0.09%)
ACB   10.67 (-1.39%)
DIS   189.17 (-0.95%)
BA   212.07 (-2.02%)
NFLX   541.19 (-1.01%)
BAC   35.01 (-2.56%)
Log in
OTCMKTS:NTRB

Nutriband Stock Forecast, Price & News

$31.00
+0.50 (+1.64 %)
(As of 02/25/2021 12:00 AM ET)
Add
Compare
Today's Range
$30.99
Now: $31.00
$31.00
50-Day Range
$12.50
MA: $19.96
$31.00
52-Week Range
$6.02
Now: $31.00
$31.00
Volume740 shs
Average Volume910 shs
Market Capitalization$193.97 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain. Its product line consists of an energy patch line; a weight management patch line; a multivitamin patch line; a children's multivitamin patch line; an amino acid patch line; an anti-wrinkle patch line; an insect repellant patch line; a detox patch line; a PMS patch line; a sleep patch line; and a nausea and motion sickness patch line. The company was incorporated in 2016 and is headquartered in Orlando, Florida.

Industry, Sector and Symbol

Industry Surgical appliances & supplies
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:NTRB
CUSIPN/A
CIKN/A
Phone407 377 6695
Employees3
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$370,000.00

Profitability

Net Income$-2,720,000.00
Net Margins-263.80%

Miscellaneous

Market Cap$193.97 million
Next Earnings Date4/13/2021 (Estimated)
OptionableNot Optionable

MarketRank

Overall MarketRank

0.71 out of 5 stars

Medical Sector

1218th out of 1,956 stocks

Surgical Appliances & Supplies Industry

32nd out of 40 stocks

Analyst Opinion: 0.0Community Rank: 2.1Dividend Strength: 0.0Insider Behavior: 0.8Valuation: 0.6 5 -4 -3 -2 -1 -
$31.00
+0.50 (+1.64 %)
(As of 02/25/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive NTRB News and Ratings via Email

Sign-up to receive the latest news and ratings for NTRB and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Nutriband (OTCMKTS:NTRB) Frequently Asked Questions

What stocks does MarketBeat like better than Nutriband?

Wall Street analysts have given Nutriband a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Nutriband wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Nutriband?

Nutriband saw a drop in short interest during the month of January. As of January 29th, there was short interest totaling 300 shares, a drop of 25.0% from the January 14th total of 400 shares. Based on an average daily volume of 1,300 shares, the short-interest ratio is presently 0.2 days.
View Nutriband's Short Interest
.

When is Nutriband's next earnings date?

Nutriband is scheduled to release its next quarterly earnings announcement on Tuesday, April 13th 2021.
View our earnings forecast for Nutriband
.

How were Nutriband's earnings last quarter?

Nutriband Inc. (OTCMKTS:NTRB) announced its quarterly earnings results on Monday, December, 14th. The company reported ($0.01) EPS for the quarter, topping analysts' consensus estimates of ($0.04) by $0.03. The business earned $0.39 million during the quarter, compared to analyst estimates of $0.24 million. Nutriband had a negative net margin of 263.80% and a negative trailing twelve-month return on equity of 53.69%.
View Nutriband's earnings history
.

Who are Nutriband's key executives?

Nutriband's management team includes the following people:
  • Mr. Sean Gallagher, Exec. Chairman & Pres (Age 58)
  • Mr. Gareth Sheridan, Founder, CEO & Director (Age 31, Pay $57k)
  • Dr. Jeffrey Patrick, Chief Scientific Officer (Age 50)
  • Mr. Gerald Goodman, CFO & Chief Accounting Officer (Age 73)
  • Dr. Alan Smith, COO & Pres of 4P Therapeutics (Age 55)
  • Mr. Patrick Ryan, Chief Technical Officer (Age 34)
  • Dr. Larry M. Dillaha, Chief Medical Officer (Age 57)
  • Mr. Michael Myer, Pres Pocono Pharmaceutical & Director (Age 36)
  • Mr. Tyler Overk, Head of Active Intelligence

Who are some of Nutriband's key competitors?

What is Nutriband's stock symbol?

Nutriband trades on the OTCMKTS under the ticker symbol "NTRB."

How do I buy shares of Nutriband?

Shares of NTRB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Nutriband's stock price today?

One share of NTRB stock can currently be purchased for approximately $31.00.

How much money does Nutriband make?

Nutriband has a market capitalization of $193.97 million and generates $370,000.00 in revenue each year. The company earns $-2,720,000.00 in net income (profit) each year or ($0.37) on an earnings per share basis.

How many employees does Nutriband have?

Nutriband employs 3 workers across the globe.

What is Nutriband's official website?

The official website for Nutriband is nutriband.com.

How can I contact Nutriband?

The company can be reached via phone at 407 377 6695.


This page was last updated on 2/26/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.